H A Koistinen
Overview
Explore the profile of H A Koistinen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
366
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Skrobuk P, von Kraemer S, Semenova M, Zitting A, Koistinen H
Diabetologia
. 2012 Aug;
55(11):3051-60.
PMID: 22898769
Aims/hypothesis: Recent studies have suggested resveratrol (RSV) as a new natural therapeutic agent to treat type 2 diabetes and lipid-induced insulin resistance. Here, we investigated whether RSV could reverse palmitate-induced...
2.
Deshmukh A, Long Y, de Castro Barbosa T, Karlsson H, Glund S, Zavadoski W, et al.
Diabetologia
. 2010 Mar;
53(6):1142-50.
PMID: 20349036
Aims/hypothesis: We investigated the direct effect of a nitric oxide donor (spermine NONOate) on glucose transport in isolated human skeletal muscle and L6 skeletal muscle cells. We hypothesised that pharmacological...
3.
Koistinen H, Remitz A, Koivisto V, Ebeling P
Diabetologia
. 2005 Dec;
49(2):383-6.
PMID: 16380803
Aims/hypothesis: We previously reported that treatment of acne with 13-cis-retinoic acid causes insulin resistance and disturbances in lipid metabolism resembling those of the insulin-resistance syndrome. It is not known whether...
4.
Koistinen H, Zierath J
J Endocrinol Invest
. 2003 Nov;
26(7):690-2.
PMID: 14594125
No abstract available.
5.
Koistinen H, Chibalin A, Zierath J
Diabetologia
. 2003 Aug;
46(10):1324-8.
PMID: 12937895
Aims/hypothesis: p38 mitogen activated protein kinase (MAPK) is generally thought to facilitate signal transduction to genomic, rather than metabolic responses. However, recent evidence implicates a role for p38 MAPK in...
6.
Koistinen H, Zierath J
Ann Med
. 2003 Jan;
34(6):410-8.
PMID: 12523496
Glucose transport, the rate limiting step in glucose metabolism in skeletal muscle, is mediated by insulin-sensitive glucose transporter 4 (GLUT4) and can be activated in skeletal muscle by two separate...
7.
Koistinen H, Remitz A, Gylling H, Miettinen T, Koivisto V, Ebeling P
Diabetes Metab Res Rev
. 2001 Dec;
17(5):391-5.
PMID: 11747145
Background: 13-cis-Retinoic acid (Roaccutan) treatment is associated with disturbances in lipid and sometimes also in glucose metabolism. Thus, we investigated whether 13-cis-retinoic acid treatment decreases insulin sensitivity. Methods: We studied...
8.
Hytinantti T, Juntunen M, Koistinen H, Koivisto V, Karonen S, Andersson S
Arch Dis Child Fetal Neonatal Ed
. 2001 Aug;
85(2):F123-6.
PMID: 11517207
Aim: To evaluate the effect of maternal diabetes on the concentrations of free and bound leptin at birth and during postnatal adaptation. Methods: Total, bound, and free leptin concentrations and...
9.
Laivuori H, Koistinen H, Karonen S, Cacciatore B, Ylikorkala O
Hum Reprod
. 2001 Jul;
16(8):1632-5.
PMID: 11473954
Background: Oral and transdermal postmenopausal hormone replacement therapy (HRT) affects lipid and glucose metabolism differently, which is of significance in the release of leptin by adipocytes. Moreover, oestrogen and progesterone...
10.
Koistinen H, Vidal H, Karonen S, Dusserre E, Vallier P, Koivisto V, et al.
Arterioscler Thromb Vasc Biol
. 2001 Jun;
21(6):1034-9.
PMID: 11397716
We studied the effect of an oral fat load on plasma acylation stimulating protein (ASP) concentrations in 9 lean healthy (age 59+/-2 years, body mass index [BMI] 23.2+/-0.4 kg/m(2); both...